The New York Times, September 21, 2020


The pandemic has many parents asking two burning questions. First, when can I get a vaccine? And second, when can my kids get it? It may come as a surprise that the answers are not the same. Adults may be able to get a vaccine by next summer. But their kids will have to wait longer. Perhaps a lot longer.

Thanks to the U.S. government’s Operation Warp Speed and other programs, a number of Covid-19 vaccines for adults are already in advanced clinical trials. But no trials have yet begun in the United States to determine whether these vaccines are safe and effective for children.

Continue reading “A Covid-19 Vaccine for Children May Not Arrive Before Fall 2021”

The New York Times, September 12, 2020


The pharmaceutical company AstraZeneca said Saturday that it had resumed its coronavirus vaccine trial in Britain after suspending it six days ago over potential safety issues but that its trials in the United States and other countries were still on hold.

The news came the same day that a competitor, Pfizer, said it was expanding the trial of its coronavirus vaccine to 44,000 people — a big increase from its previous goal of 30,000 — in an effort to recruit a more diverse group of participants and potentially cut down the time needed to get results from the trial.

Continue reading “AstraZeneca Partly Resumes Coronavirus Vaccine Trial After Halting It for Safety”

The New York Times, September 4, 2020


On Friday, a team of Russian scientists published the first report on their Covid-19 vaccine, which had been roundly criticized because of President Vladimir Putin’s decision last month to approve it before clinical trials had proved it safe and effective.

In a small group of volunteers, the scientists found that the vaccine produced a modest level of antibodies against the coronavirus, while causing only mild side effects. The research has not yet shown, however, whether people who are vaccinated are less likely to become infected than those who are not.

Continue reading “Russians Publish Early Coronavirus Vaccine Results”

The New York Times, September 2, 2020


In planning documents sent last week to public health agencies around the country, the Centers for Disease Control and Prevention described preparations for two coronavirus vaccines they refer to simply as Vaccine A and Vaccine B. The technical details of the vaccines, including the time between doses and their storage temperatures, match well with the two vaccines furthest along in clinical tests in the United States, made by Moderna and Pfizer.

Here’s what you need to know about how the vaccines work, how they’re being tested and how they might be rolled out to the public — if, and it’s still a big if, they are proven to work.

Continue reading “What We Know About the C.D.C.’s Covid-19 Vaccine Plans”

The New York Times, August 28, 2020


For four days, the Republican National Convention projected the image of a nation that had beaten the coronavirus, with maskless supporters packed close together and free to carry on with their lives thanks to the quick, powerful and effective response of President Trump, who crushed a pandemic when it reached American shores.

The truth is another story.

With more than 180,000 Americans dead and the economy still mired in recession, no issue threatens Mr. Trump’s re-election like the coronavirus. 

Continue reading “For Trump, G.O.P. Created an Alternative America Beyond Covid-19”